• news.cision.com/
  • Viedoc/
  • New partnership with Peking University – provides cloud-based EDC from within China

New partnership with Peking University – provides cloud-based EDC from within China

Report this content

Viedoc today announced its partnership with Peking University Clinical Research Institute (PUCRI), a world-renowned academic center dedicated to enhancing the development of high-quality clinical research and health innovation in China.

The partnership will accelerate the adoption of the Viedoc platform across the Chinese clinical research sector and, in doing so, help life sciences companies improve operational efficiencies and increase productivity across China's clinical research programs.

Yvonne Zhou, MD Viedoc China, Prof Yangfeng Wu, Professor of Epidemiology at Peking University School of Public Health and Executive Associate Director at PUCRI, Thomas Kaponen, General Manager Viedoc China, Henrik Blombergsson, Founder and COO Viedoc and Gaoqiang Xie, Technology and Executive Director and Associate Professor at the Department of Data Management.

PUCRI has a wide range of partners within the clinical research sector, including government organizations, over 300 hospitals, hundreds of pharmaceutical companies and CROs across the country. As a result of PUCRI’s partnership with Viedoc, the university will be provided with cloud-based EDC technology, served from servers within China.

"We are delighted to initiate a partnership with Viedoc. Being able to store data within China is extremely important for Chinese domestic companies. By working with Viedoc, we look forward to advancing clinical development in China and serving as a bridge between top modern EDC technology and innovative drug development", says Prof Yangfeng Wu at PUCRI.

Yvonne Zhou, Viedoc’s managing director in China, says: "This is a collaboration that benefits all parties. Leveraging PUCRI's clinical trial expertise will enable us to serve more life sciences organizations in China and to accelerate drug development, allowing patients to access new therapies faster, both from the local market and around the world."

About Peking University Clinical Research Institute (PUCRI)

 Peking University Clinical Research Institute (PUCRI) was founded in 2008, under the direct leadership of Peking University Health Science Center (PUHSC), as the first university-established public platform in China specialized in teaching, research, services, training, organizational coordination and technical support of clinical research. The institute also hosts the Peking University - APEC Regulatory Science Center of Excellence.

PUCRI is committed to improving clinical research in China, to promote the innovation in clinical medicine and hence people's well-being. PUCRI provides technical support to various clinical studies including new drug development, specifically research design, execution, quality management, data management and statistical analysis.

For more information, please contact:
Yvonne Zhou, Managing Director Viedoc China, yvonne.zhou@viedoc.com
John Overend, Managing Director Sales and Marketing Viedoc, john.overend@viedoc.com
Henrik Blombergsson, Co-founder & COO Viedoc, henrik.blombergsson@viedoc.com

Viedoc is a modern and future-proof EDC system that allows clinical trial sponsors and study sites to easily and securely collect, validate, transmit and analyze clinical study data. A proven software since 2003 which meets or surpasses all regulatory benchmarks. Designed to be as intuitive as possible, Viedoc saves time and frustration from users at every level, allowing clinical trial organizations to have more focus on their own innovation and leadership. www.viedoc.com

Media

Media

Documents & Links

Quotes

By working with Viedoc, we look forward to advancing clinical development in China and serving as a bridge between top modern EDC technology and innovative drug development.
Prof Yangfeng Wu, PUCRI